by Sameer Laul | Jan 10, 2023 | News
PROVIDENCE, RI, January 10, 2023 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) and Zoetis, are pleased to announce an exclusive collaboration to develop CircoMatch™, a unique bioinformatics tool that predicts the coverage of Porcine Circovirus Type 2 (PCV2) vaccines...
![EpiVax, Inc. Subsidiary, EpiVax Therapeutics Signs Exclusive Collaboration Agreement with GreenLight Biosciences to Develop Personalized Cancer Vaccines]()
by Sameer Laul | Jan 9, 2023 | News
EpiVax, Inc. is excited to announce that its subsidiary, EpiVax Therapeutics, has signed an exclusive collaboration agreement with GreenLight Biosciences to advance the development of personalized cancer vaccines. The effort will combine GreenLight’s mRNA...
by Sameer Laul | Jan 6, 2023 | News
“I have found that among its other benefits, giving liberates the soul of the giver.” – Maya Angelou EpiVax’s VaxGivesBack Fund kicked the holiday off by partnering with AIDS Care Ocean State and Clinica Esperanza/Hope Clinic to distribute gifts to local...
